← Scroll for more →
Financial Statements — IVA
Balance Sheet
(in millions EUR)| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 122.08 | 96.56 | 10.15 | 26.92 | 31.24 | 86.74 | 86.55 |
| Inventory | -- | 0.00 | 0.39 | 0.42 | 0.40 | 0.37 | 0.39 |
| Total Current Assets | 172.81 | 111.51 | 28.61 | 48.19 | 52.37 | 106.38 | 115.58 |
| Total Non-current Assets | 6.14 | 7.46 | 10.82 | 21.37 | 18.45 | 9.62 | 6.41 |
| Total Assets | 178.96 | 118.97 | 39.43 | 69.56 | 70.82 | 116.00 | 121.99 |
| Total Current Liabilities | 58.46 | 120.73 | 48.15 | 50.16 | 37.80 | 30.70 | 22.85 |
| Total Non-current Liabilities | 129.41 | 104.88 | 70.34 | 51.43 | 40.69 | 39.83 | 10.27 |
| Total Liabilities* | 187.86 | 225.61 | 118.49 | 101.59 | 78.49 | 70.53 | 33.12 |
| Total Stockholder Equity | (8.91) | (106.65) | (79.06) | (32.03) | (7.67) | 45.48 | 88.87 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Total Revenue | 4.45 | 0.04 | 1.90 |
| Research & Development | 44.89 | 46.82 | 54.06 |
| Selling, General & Admin | 14.71 | 7.70 | 6.81 |
| Operating Income | (62.94) | (52.25) | (55.00) |
| Interest Expense | 9.72 | 5.22 | 1.94 |
| Pretax Income* | (176.38) | (48.91) | (55.28) |
| Tax Provision | (0.50) | 0.12 | (0.01) |
| Net Income | (175.88) | (49.03) | (55.27) |
| Basic EPS | (1.62) | (0.94) | (1.31) |
| Diluted EPS | (1.62) | (0.94) | (1.31) |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Operating Cash Flow | (53.72) | (48.34) | (45.23) |
| Investing Cash Flow | (24.80) | 8.91 | (7.70) |
| Financing Cash Flow | 104.78 | 22.57 | (2.15) |
← Scroll for more columns →